![James Ryan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 460 080 $ al 31/05/2026
James Ryan currently works at Law Society of Ireland, as Member and BioNTech SE, as Chief Legal & Business Officer from 2024.
Dr. Ryan also formerly worked at GW Pharmaceuticals Ltd., as Head-Legal Affairs.
Dr. Ryan received his doctorate degree from the University of St. Andrews School of Management.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BIONTECH SE 0 % | 12/05/2026 | 4.795 ( 0 % ) | 460 080 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BIONTECH SE | Consejero General | 01/07/2018 |
Law Society of Ireland | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
| GW PHARMACEUTICALS PLC | Consejero General | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
GW Pharmaceuticals Ltd.
 GW Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets novel therapeutics | Health Technology |
Law Society of Ireland | |
BioNTech SE
 BioNTech SE BiotechnologyHealth Technology Develops immunotherapies and mRNA-based vaccines to treat cancer & infectious diseases | Health Technology |
University of St. Andrews School of Management
 University of St. Andrews School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
